CURE Pharmaceutical Holding Corp. CURR revenue within the third quarter elevated 32.1% year-over-year and 58.9% sequentially from Q2 2022 to $1.8 million.
Q3 2022 Monetary Highlights
Gross revenue was $1.4 million in comparison with $914,000 in Q3 2021.
Gross margins for the third quarter improved by 123 foundation factors to 80.0% in 2022 in comparison with the identical interval in 2021.
Web loss was $3.6 million in comparison with $4.3 million in Q3 2021.
CURE accomplished the sale of a portion of its platform expertise mental property portfolio and associated belongings in July 2022 for $20 million of non-dilutive capital in complete consideration. The corporate retained 15 of its patents and can proceed to be an incubator for future applied sciences and patents, which it intends to monetize via the commercialization of the applied sciences via product improvement or via the licensing or sale of the applied sciences.
CURE’s wholly owned subsidiary, The Sera Labs, began promoting six SKUs of its Seratopical Revolution skincare line with P3P, the proprietary supply system, at 1,372 Walmart Shops in addition to on Amazon.com.
Sera Labs additionally has garnered placement for its oral skinny movie strip, Nutri-Strips on cabinets at CVS, Amazon.com and Goal.com. Nutri-Strips are proprietary to Sera Labs and are the results of years of analysis.
Board of Administrators and Governance Replace
In August the corporate appointed Gerald Bagg and Robert J. Costantino to its board of administrators and Costantino has additionally been appointed as chairman of CURE’s Audit Committee. Former CURE CEO Rob Davidson was appointed as chairman of the board of administrators.
Get your each day dose of cannabis news on Benzinga Hashish. Don’t miss out on any essential developments within the business.
Photograph by Mackenzie Marco on Unsplash
CURE Pharmaceutical Q2 2021 Revenue Spikes 700% After Increased Sales From Sera Labs Products Including A CVS Deal
© 2022 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
BENZINGA CANNABIS CONFERENCE
Meet the most important hashish business gamers and make offers that may push the business ahead.
That includes stay firm displays, insider panels, and unmatched entry to networking, the Benzinga Cannabis Capital Conference is the place hashish executives and entrepreneurs meet.
Be a part of us April 11-12, 2023 at Fontainebleau Miami Seaside in sunny Florida.